carmustine has been researched along with Hepatic Veno Occlusive Disease in 8 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intensive doses of carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support were given to four patients with advanced melanoma." | 3.68 | High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity. ( Affronti, ML; Coniglio, D; Jones, RB; Peters, WP; Ross, M; Shpall, EJ, 1990) |
| "Sinusoidal obstruction syndrome is a rare complication of autologous hematopoietic stem cell transplantation." | 2.58 | [Sinusoidal obstruction syndrome after BeAM conditioning regiment for autologous stem cell transplantation: Imputability of bendamustine? Report of two cases and literature review]. ( Fornecker, LM; Guffroy, A; Korganow, AS; Martin, M; Meyer, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lavolé, J | 1 |
| Le Goff, M | 1 |
| Oudjit, A | 1 |
| Sogni, P | 1 |
| Mallet, V | 1 |
| Meyer, A | 1 |
| Fornecker, LM | 1 |
| Guffroy, A | 1 |
| Korganow, AS | 1 |
| Martin, M | 1 |
| Annaloro, C | 1 |
| Robbiolo, L | 1 |
| Pozzoli, E | 1 |
| Ibatici, A | 1 |
| Nicolini, A | 1 |
| Salerno, F | 1 |
| Deliliers, GL | 1 |
| Puig, N | 1 |
| de la Rubia, J | 1 |
| Remigia, MJ | 1 |
| Jarque, I | 1 |
| Martín, G | 1 |
| Cupelli, L | 1 |
| Sanz, GF | 1 |
| Lorenzo, I | 1 |
| Sanz, J | 1 |
| Martínez, JA | 1 |
| Jiménez, C | 1 |
| Sanz, MA | 1 |
| Castenskiold, EC | 1 |
| Kelsey, SM | 1 |
| Collins, PW | 1 |
| Coldwell, RD | 1 |
| Allen, PD | 1 |
| Side, LE | 1 |
| Makin, HL | 1 |
| Goldstone, AH | 1 |
| Newland, AC | 1 |
| Klingemann, HG | 1 |
| Shepherd, JD | 1 |
| Reece, DE | 1 |
| Barnett, MJ | 1 |
| Nantel, SH | 1 |
| Sutherland, HJ | 1 |
| Spinelli, JJ | 1 |
| Phillips, GL | 1 |
| Jones, RB | 1 |
| Shpall, EJ | 1 |
| Ross, M | 1 |
| Coniglio, D | 1 |
| Affronti, ML | 1 |
| Peters, WP | 1 |
| Ayash, LJ | 1 |
| Hunt, M | 1 |
| Antman, K | 1 |
| Nadler, L | 1 |
| Wheeler, C | 1 |
| Takvorian, T | 1 |
| Elias, A | 1 |
| Antin, JH | 1 |
| Greenough, T | 1 |
| Eder, JP | 1 |
2 reviews available for carmustine and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
[Sinusoidal obstruction syndrome after BeAM conditioning regiment for autologous stem cell transplantation: Imputability of bendamustine? Report of two cases and literature review].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Cytara | 2018 |
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Tr | 1994 |
1 trial available for carmustine and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamid | 2006 |
5 other studies available for carmustine and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Abdominal computed tomography angiography in post-transplantation sinusoidal obstruction syndrome associated with R-DHAOX/BEAM toxicity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Computed Tomography Angiography; C | 2018 |
Four-year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation.
Topics: Adult; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Hemodynamics; Hepatic Ven | 2004 |
Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopterins; Bone Marr | 1995 |
High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Car | 1990 |
Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
Topics: Adult; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Female; Hepatic Veno-Occl | 1990 |